trial · primary record
Nalmefene
AUD
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 13 |
| Primary completion | 2023-12-08 |
| Primary endpoint | Nalmefene-induced BOLD signal changes in neural regions associated with alcohol reward processing, including ventral striatum, amygdala, and insula |
| Registry ID | NCT02639273 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:13.231Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02639273
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.